🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

There were significant differences among the 4 molecular subtypes of #EndometrialCancer Figures below highlight - Most common mutations for POLE - Distribution of molecular subtypes by histology - Tumor mutational burden (TMB) of subtypes - Fraction genome altered (FGA) of

QIMR Berghofer's Cancer Program is looking for a new lab head. Come join us in sunny Brisbane! Please RT bit.ly/44FMYwh

Great story from Bec Pridham Uterine and other gynaecological cancers on the rise but many women in the dark, expert says abc.net.au/news/2023-07-2… via ABC Australia Am working hard to lead the EDEN initiative to make progress in this space with a new group and new trials ANZGOG

Registrations are open for our ABACBS 2023 conference to be held in sunny Brisbane in December! We're super excited to be partnering with ISCB News for the first time in our history, which will include discounted ISCB memberships for ABACBS 2023 attendees 2023.abacbs.org

🙌Our #CherishTeam Kilimanjaro trekkers hit a milestone on the weekend - over $100k raised already. Help them achieve their target and don’t miss this opportunity to be part of the action. They start trekking in just over two weeks. Donate today!🧡bit.ly/40IcL4S

The emperor of all oncogenes…once deemed undruggable... Kirsten rat sarcoma virus (KRAS). After G12C inhibitors…G12D is next… #OpenAccess #Researchpaper in Trends in Cancer on ongoing developments & #clinicaltrials #PrecisionMedicine OncoAlert 🚨 cell.com/trends/cancer/…

Hey ABACBS community! Have you registered for our ABACBS conference in Brisbane yet? It's less than one month to go before our call for abstracts closes and you don't want to miss out! Submit yours today! We've gotten abstracts from as far as India, Korea, and Europe! 🥳🏖️🐨

Only 2 weeks to go until Abstract Submission closes for our ABACBS conference! Submit your abstract today for a chance to present a poster or talk. We are offering a fun & supportive environment to present your work regardless of your current career stage.

.Medical Genomics @QIMR Olga Kondrashova Khoa Tran use #BreastCancer #scRNAseq data to simulate bulk RNA-seq data with which they compare the performance of nine #TumorMicroenvironment #deconvolution methods #CancerResearch Cancer at Nature Portfolio nature.com/articles/s4146…

**DEADLINE EXTENSION** for abstract submissions is now Fri 29 Sep 11:59pm!! So if you just missed out or were on the fence, here's your sign that the @ABACBS conference needs you too! 🤩Come join us 4-8 Dec at #Australia's best #bioinformatics conference! 2023.abacbs.org

Workshops, symposia and satellites are a beloved annual tradition for the ABACBS conference! We're proud to release our 2023 offering and acknowledge the organisers who are contributing these important events to our conference week. Head to 2023.abacs.org for more info!

The #gnomAD team is proud to announce the release of gnomAD v4! The v4 dataset includes 730,947 exomes & 76,215 genomes, which is ~5x larger than the v2 & v3 releases combined, & includes nearly 120K indivs of non-European genetic ancestry broad.io/gnomad_v4 #ASHG23 (1/11)

Huge congratulations to all #UQCCR Director Award recipients including our very own Amy McCart for winning 'MCR Supervisor of the Year' third time running 😁🎉👏 UQ Medicine UQ News

Stronger together, this #OvarianCancerAwarenessMonth ANZGOG, @ocrfaustralia and Ovarian Cancer Aust are committed to working and advocating together to ensure ovarian cancer is a national priority to drive the significant change needed to have a powerful impact on future

🧬 The Silent Culprits of Cancer: Aberrant DNA Methylation! Learn how epigenetic alterations can impact cancer risk, clinical decisions, and treatment responses Explore the findings by @NesicKsenija Olga Kondrashova liz swisher Clare Scott Matthew Wakefield : journals.sagepub.com/doi/full/10.11…

For all those Binfies in the ABACBS community who are planning 2024-25 funding applications, we are planning a new fellowship/grant workshop which will be running on March 19th at 1pm AEDT hosted by Shila Ghazanfar. #SaveTheDate

High-level tumour methylation of BRCA1 and RAD51C is required for homologous recombination deficiency in solid cancers. This study comprehensively investigated promoter methylation of eight homologous recombination repair genes across 23 solid cancer types academic.oup.com/narcancer/arti…

Read our latest: BRCA1 and RAD51C methylation surveyed across 23 solid cancers - required for HR deficiency and possible therapeutic biomarker. From Olga Kondrashova and coworkers, QIMR Berghofer. academic.oup.com/narcancer/arti…

Feeling proud to share with you our very first publication from the lab! 🥂🎉 Big kudos to everyone involved, but especially Lijun Xu for all her hard work. QIMR Berghofer @WEHI

Latest paper from us showing PARP inhibitor resistance caused by 2ndry mutations that alter splicing Nesic, K., Krais, J.J., Wang, Y. et al. BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance. Mol Cancer 23, 158 (2024). doi.org/10.1186/s12943…